China Pharma Holdings
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.50-2.22-6.16-1.98-5.21-2.45-30.76-28.24-2.46-0.66-0.02-5.21
Price/Sales ratio
2.941.683.632.894.544.728.9411.543.110.290.014.72
Price/Book Value ratio
0.610.470.960.881.855.5812.1418.495.880.270.035.58
Price/Cash Flow ratio
14.2610.2119.5645.4844.6184.82-2.30K-445.52-61.61-2.92-0.0984.82
Price/Free Cash Flow ratio
-51.3233.1920.9654.2946.51109.24-106.90-161.81-31.09-2.87-0.07109.24
Price/Earnings Growth ratio
-0.080.050.15-0.010.11-0.020.36-1.56-0.010.010.020.02
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
12.05%7.19%20.67%18.68%16.01%13.56%17.97%3.62%-6.09%-4.00%-7.88%13.56%
Operating Profit Margin
-165.11%-69.75%-26.93%-34.02%-32.18%-31.02%-22.61%-32.31%-43.79%-39.24%-46.28%-31.02%
Pretax Profit Margin
-178.34%-75.39%-56.99%-144.97%-88.07%-189.51%-26.38%-35.25%-49.02%-43.91%-52.03%-88.07%
Net Profit Margin
-117.68%-75.69%-58.97%-145.90%-87.18%-192.45%-29.08%-40.87%-126.12%-43.91%-52.03%-87.18%
Effective Tax Rate
-0.19%-0.39%-3.47%-0.64%-1.01%-1.55%-10.26%-15.94%-157.28%N/AN/A-1.01%
Return on Assets
-19.72%-15.84%-11.69%-32.15%-23.69%-94.55%-14.96%-17.40%-57.47%-18.69%-33.12%-94.55%
Return On Equity
-24.51%-21.20%-15.58%-44.75%-35.59%-227.58%-39.48%-65.49%-238.26%-41.30%-142.89%-227.58%
Return on Capital Employed
-30.99%-16.81%-6.15%-8.86%-11.23%-27.80%-25.29%-25.67%-70.35%-28.52%-103.87%-27.80%
Liquidity Ratios
Current Ratio
3.841.951.681.330.870.550.46N/AN/AN/A0.460.55
Quick Ratio
2.761.190.980.630.360.190.140.540.230.330.190.19
Cash ratio
0.370.480.250.220.110.100.080.460.150.200.150.11
Days of Sales Outstanding
421.8598.0199.0267.8532.1722.7819.5931.6220.9134.4813.5922.78
Days of Inventory outstanding
287.29186.73216.03217.67178.16138.73151.72131.17125.13186.8288.09138.73
Operating Cycle
709.15284.74315.05285.52210.34161.52171.31162.80146.05221.3091.44161.52
Days of Payables Outstanding
47.8347.1490.4338.7637.3952.8150.5536.4028.3148.3719.9352.81
Cash Conversion Cycle
661.32237.60224.62246.75172.95108.70120.75126.40117.73172.9315.37108.70
Debt Ratios
Debt Ratio
0.130.170.140.160.170.290.340.540.490.270.750.17
Debt Equity Ratio
0.160.230.180.230.250.700.922.052.030.603.140.25
Long-term Debt to Capitalization
0.090.120.120.130.120.180.100.46N/A0.15N/A0.18
Total Debt to Capitalization
0.140.180.150.180.200.410.470.670.670.37N/A0.41
Interest Coverage Ratio
-2.97-3.47-3.65-5.75-7.45-10.53-8.37N/AN/AN/A-7.83-10.53
Cash Flow to Debt Ratio
0.250.190.250.080.160.09-0.00-0.02-0.04-0.15N/A0.09
Company Equity Multiplier
1.241.331.331.391.502.402.633.764.142.204.141.50
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.200.160.180.060.100.05-0.00-0.02-0.05-0.09-0.140.05
Free Cash Flow / Operating Cash Flow Ratio
-0.270.300.930.830.950.7721.522.751.981.011.350.95
Cash Flow Coverage Ratio
0.250.190.250.080.160.09-0.00-0.02-0.04-0.15N/A0.09
Short Term Coverage Ratio
0.700.541.140.270.360.14-0.00-0.03-0.04-0.22-40.120.14
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A